Reduced Cellular Susceptibility to In Vitro HIV Infection Is Associated with CD4+ T Cell Quiescence

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Card, Catherine M ^a,d   Rutherford, W John ^a   Ramdahin, Suzie ^a   Yao, Xiaojian ^a   Kimani, Makobu ^b   Wachihi, Charles ^b   Kimani, Joshua ^b   Plummer, Francis A ^a,c   Ball, T Blake ^a,b,c   Fowke, Keith R ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFECTION SENSITIVITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE RESISTANCE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; VIRUS REPLICATION;

EID: 84866717332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045911     Document Type: Article

References (39)

1. McKinnon LR, Kaul R, (2012) Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Current Opinion in HIV and AIDS 7: 195-202.
2. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
3. Zhang Z-Q, Wietgrefe SW, Li Q, Shore MD, Duan L, et al. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640-5645.
4. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen. Science 319: 921-926.
5. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GMC, et al. (2008) Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication. Cell 135: 49-60.
6. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-Scale RNAi Screen for Host Factors Required for HIV Replication. Cell Host and Microbe 4: 495-504.
7. Deeks SG, (2004) Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104: 942-947.
8. Giorgi J, Hultin L, McKeating J, (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179: 859-870.
9. Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, et al. (2002) Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 29: 346-355.
10. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197: 126-133.
11. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr 16: 83-92.
12. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, et al. (2009) Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis 199: 1318-1322.
13. McLaren P, Ball T, Wachihi C, Jaoko W, Kelvin D, et al. (2010) HIV-Exposed Seronegative Commercial Sex Workers Show a Quiescent Phenotype in the CD4+ T Cell Compartment and Reduced Expression of HIV-Dependent Host Factors. J Infect Dis 202: S339-S344.
14. Songok EM, Luo M, Liang B, McLaren P, Kaefer N, et al. (2012) Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State. PLoS ONE 7: e30048.
15. Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, et al. (2005) Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 175: 6117-6122.
16. Camara M, Dieye TN, Seydi M, Diallo AA, Fall M, et al. (2010) Low-level CD4+ T cell activation in HIV-exposed seronegative subjects: influence of gender and condom use. J Infect Dis 201: 835-842.
17. Begaud E, Chartier L, Marechal V, Ipero J, Leal J, et al. (2006) Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3: 35.
18. Jennes W, Evertse D, Borget M-Y, Vuylsteke B, Maurice C, et al. (2006) Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers. Clin Exp Immunol 143: 435-444.
19. Salkowitz JR, Purvis SF, Meyerson H, Zimmerman P, O'Brien TR, et al. (2001) Characterization of high-risk HIV-1 seronegative hemophiliacs. Clin Immunol 98: 200-211.
20. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
21. Spina CA, Guatelli JC, Richman DD, (1995) Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J Virol 69: 2977-2988.
22. Tang S, Patterson B, Levy JA, (1995) Highly purified quiescent human peripheral blood CD4+ T cells are infectible by human immunodeficiency virus but do not release virus after activation. J Virol 69: 5659-5665.
23. Zack JA, Haislip AM, Krogstad P, Chen IS, (1992) Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J Virol 66: 1717-1725.
24. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, et al. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1: 1284-1290.
25. Vatakis DN, Bristol G, Wilkinson TA, Chow SA, Zack JA, (2007) Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells. J Virol 81: 3574-3582.
26. Korin YD, Zack JA, (1998) Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 72: 3161-3168.
27. Moreno-Fernandez ME, Rueda CM, Rusie LK, Chougnet CA, (2011) Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood 117: 5372-5380.
28. Moreno-Fernandez ME, Rueda CM, Velilla PA, Rugeles MT, Chougnet CA (2011) cAMP During HIV Infection: Friend or Foe? AIDS research and human retroviruses.
29. Navarro J, Punzón C, Jiménez JL, Fernández-Cruz E, Pizarro A, et al. (1998) Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT. J Virol 72: 4712-4720.
30. Sun Y, Li L, Lau F, Beavo JA, Clark EA, (2000) Infection of CD4+ memory T cells by HIV-1 requires expression of phosphodiesterase 4. J Immunol 165: 1755-1761.
31. Banas B, Eberle J, Banas B, Schlöndorff D, Luckow B, (2001) Modulation of HIV-1 enhancer activity and virus production by cAMP. FEBS letters 509: 207-212.
32. Oswald-Richter K, Grill SM, Shariat N, Leelawong M, Sundrud MS, et al. (2004) HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2: E198.
33. Antons AK, Wang R, Oswald-Richter K, Tseng M, Arendt CW, et al. (2008) Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J Immunol 180: 764-773.
34. Moreno-Fernandez ME, Zapata W, Blackard JT, Franchini G, Chougnet CA, (2009) Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. J Virol 83: 12925-12933.
35. Miller CJ, Li Q, Abel K, Kim E-Y, Ma ZM, et al. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79: 9217-9227.
36. Haase AT, (2010) Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217-223.
37. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, et al. (2009) Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038.
38. Lane JR, (1999) Isolation and Expansion of HIV from Cells and Body Fluids by Coculture. Methods Mol Med 17: 3-10.
39. Land AM, Ball TB, Luo M, Rutherford J, Sarna C, et al. (2008) Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants. AIDS Res Hum Retroviruses 24: 865-872.